Pfizer to repurpose warehouse space in $150m Michigan investment
Pfizer will convert warehouse space at its Kalamazoo-Portage plant to provide extra manufacturing capacity for sterile injectable products.
Pfizer will convert warehouse space at its Kalamazoo-Portage plant to provide extra manufacturing capacity for sterile injectable products.
The MHRA has granted Oxford Biomedica permission to develop and manufacture cell therapies at two more sites in the UK.
Hemispherx Biopharma has hired Avrio Biopharmaceuticals to make Ampligen while it continues to try and win US approval for rejected candidate chronic fatigue syndrome (CFS) drug candidate.
AstraZeneca says it will be critical to avoid duplicated regulatory efforts and costs once the UK leaves the European Union.
Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.
The acquisition formalizes an existing relationship and expands the company’s offerings, allowing for “new levels of innovation,” says CEO.